| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.6B | $1.5B | $1.4B | $1.3B | $0.4B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.0B | $-0.0B | $0.1B | $0.0B | $0.0B | $-0.0B |
| EPS (Basic) | $3.93 | $2.49 | $1.09 | $-0.06 | $3.40 | $1.14 | $0.79 | $-0.49 |
| EPS (Diluted) | $3.90 | $2.48 | $1.09 | $-0.06 | $3.39 | $1.13 | $0.78 | $-0.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.3B | $14.5B | $14.0B | $13.4B | $14.4B | $13.5B | $12.5B | $11.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $13.8B | $13.2B | $12.9B | $12.4B | $12.6B | $11.7B | $10.9B | $9.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.5B | $1.3B | $1.2B | $1.1B | $1.8B | $1.8B | $1.6B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.3B | $0.2B | $0.2B | $0.3B | $0.1B | $0.2B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.1B | $-0.2B | $-0.3B | $-0.4B | $0.1B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.3B | $-0.2B | $-0.0B | $0.2B | $0.1B | $-0.2B | $-0.0B |